CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease

Brain atrophy and altered CSF levels of amyloid β (Aβ(42)) and the microtubule-associated protein tau are potent biomarkers of Alzheimer's disease (AD)-related pathology. However, the relationship between CSF biomarkers and brain morphometry is poorly understood. Thus, we addressed the followin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fjell, Anders M., Walhovd, Kristine B., Fennema-Notestine, Christine, McEvoy, Linda K., Hagler, Donald J., Holland, Dominic, Brewer, James B., Dale, Anders M.
Format: Artigo
Idioma:Inglês
Publicat: Society for Neuroscience 2010
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828879/
https://ncbi.nlm.nih.gov/pubmed/20147537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.3785-09.2010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars